Impact of high-performance HPV testing to improve cervical cancer screening in China: A prospective population-based multicenter cohort study
CONCLUSIONS: The study has indicated that HBRT-14 has a reliable clinical performance for use in cervical screening. The validated HPV test would improve the quality of population screening.PMID:38599463 | DOI:10.1016/j.cmi.2024.03.035
Source: Cancer Control - Category: Cancer & Oncology Authors: Jian Yin Shaokai Zhang Zhifang Li Yufei Li Hong Wang Xun Zhang Qinjing Pan Wen Chen Xiping Luo Xibin Sun Fanghui Zhao Youlin Qiao Source Type: research
More News: Cancer | Cancer & Oncology | Cervical Cancer | China Health | Cytology | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Reflex Sympathetic Dystrophy | Study | Women